BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crookston K, Reiner A, Cooper L, Sacher R, Blajchman M, Heddle N. RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion 2000;40:801-12. [DOI: 10.1046/j.1537-2995.2000.40070801.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Chan Y, Chang F, Wang C, Lin M. Thomsen-Friedenreich activation in infants with necrotizing enterocolitis in Taiwan: T ACTIVATION IN NECROTIZING ENTEROCOLITIS. Transfusion 2011;51:1972-6. [DOI: 10.1111/j.1537-2995.2011.03106.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Scobell RR, Kaplan BS, Copelovitch L. New insights into the pathogenesis of Streptococcus pneumoniae–associated hemolytic uremic syndrome. Pediatr Nephrol 2020;35:1585-91. [DOI: 10.1007/s00467-019-04342-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Boralessa H, Modi N, Cockburn H, Malde R, Edwards M, Roberts I, Letsky E. RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice. Transfusion 2002;42:1428-34. [PMID: 12421215 DOI: 10.1046/j.1537-2995.2002.00237.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
4 Johnson S, Taylor CM. Hemolytic Uremic Syndrome. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric Nephrology. Berlin: Springer Berlin Heidelberg; 2009. pp. 1155-80. [DOI: 10.1007/978-3-540-76341-3_48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Tran AK, Sapkota A, Wen J, Li J, Takei M. Linear relationship between cytoplasm resistance and hemoglobin in red blood cell hemolysis by electrical impedance spectroscopy & eight-parameter equivalent circuit. Biosensors and Bioelectronics 2018;119:103-9. [DOI: 10.1016/j.bios.2018.08.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Singh AK, Osman AS, Woodiga SA, White P, Mahan JD, King SJ. Defining the role of pneumococcal neuraminidases and O-glycosidase in pneumococcal haemolytic uraemic syndrome. J Med Microbiol 2016;65:975-84. [PMID: 27469261 DOI: 10.1099/jmm.0.000322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
7 Smith A, Johnston C, Inverarity D, Slack M, K Paterson G, Diggle M, Mitchell T. Investigating the role of pneumococcal neuraminidase A activity in isolates from pneumococcal haemolytic uraemic syndrome. J Med Microbiol 2013;62:1735-42. [PMID: 23924664 DOI: 10.1099/jmm.0.063479-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
8 Prestidge C, Wong W. Ten years of pneumococcal-associated haemolytic uraemic syndrome in New Zealand children. Journal of Paediatrics and Child Health 2009;45:731-5. [DOI: 10.1111/j.1440-1754.2009.01603.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
9 Gilbert RD, Nagra A, Haq MR. Does dysregulated complement activation contribute to haemolytic uraemic syndrome secondary to Streptococcus pneumoniae? Med Hypotheses 2013;81:400-3. [PMID: 23786906 DOI: 10.1016/j.mehy.2013.05.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
10 Hopkins CK, Yuan S, Lu Q, Ziman A, Goldfinger D. A severe case of atypical hemolytic uremic syndrome associated with pneumococcal infection and T activation treated successfully with plasma exchange. Transfusion 2008;48:2448-52. [DOI: 10.1111/j.1537-2995.2008.01871.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
11 Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 2004;19:317-21. [PMID: 14714171 DOI: 10.1007/s00467-003-1382-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
12 Oliver JW, Akins RS, Bibens MK, Dunn DM. Pneumococcal Induced T-activation with Resultant Thrombotic Microangiopathy. Clin Med Insights Pathol 2010;3:13-7. [PMID: 21151550 DOI: 10.4137/cpath.s670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
13 Johnson S, Waters A. Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome? Immunobiology 2012;217:235-43. [PMID: 21852019 DOI: 10.1016/j.imbio.2011.07.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
14 Loupiac A, Elayan A, Cailliez M, Adra A, Decramer S, Thouret M, Harambat J, Guigonis V. Diagnosis of Streptococcus pneumoniae–associated Hemolytic Uremic Syndrome. Pediatric Infectious Disease Journal 2013;32:1045-9. [DOI: 10.1097/inf.0b013e31829ee872] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
15 des Roziers NB, Bodivit G, Chadebech P, Nzouakou R, Bierling P, Noizat-pirenne F. Anti-T haemolysins: the effects of sialic acid removal and 2-aminoethylisothiouronium bromide treatment of erythrocytes on immune lysis: Anti-T haemolysins. Vox Sanguinis 2011;100:401-8. [DOI: 10.1111/j.1423-0410.2010.01450.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
16 Syed S, Hakala P, Singh AK, Lapatto HAK, King SJ, Meri S, Jokiranta TS, Haapasalo K. Role of Pneumococcal NanA Neuraminidase Activity in Peripheral Blood. Front Cell Infect Microbiol 2019;9:218. [PMID: 31297339 DOI: 10.3389/fcimb.2019.00218] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Bitzan M, AlKandari O, Whittemore B, Yin XL. Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic concept. Int J Med Microbiol 2018;308:1096-104. [PMID: 30177469 DOI: 10.1016/j.ijmm.2018.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
18 Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, Inward C, Jones C, Pichon B, Reid C, Slack MP, Van't Hoff W, Dillon MJ, Taylor CM, Tullus K. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr 2007;151:140-4. [PMID: 17643764 DOI: 10.1016/j.jpeds.2007.03.055] [Cited by in Crossref: 110] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
19 Winters JL. Plasma exchange in thrombotic microangiopathies (TMAs) other than thrombotic thrombocytopenic purpura (TTP). Hematology Am Soc Hematol Educ Program 2017;2017:632-8. [PMID: 29222314 DOI: 10.1182/asheducation-2017.1.632] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
20 Jimenez M, Sanz C, Alvarez A, Pereira A. Massive intravascular haemolysis in a patient with Clostridium perfringens sepsis: Letters. Vox Sanguinis 2002;82:214-214. [DOI: 10.1046/j.1423-0410.2002.00174.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
21 Villa CH, Cines DB, Siegel DL, Muzykantov V. Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond. Transfus Med Rev 2017;31:26-35. [PMID: 27707522 DOI: 10.1016/j.tmrv.2016.08.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
22 Kinney S. Pediatric Transfusion Medicine. In: Mccullough J, editor. Transfusion Medicine. Wiley; 2021. pp. 343-58. [DOI: 10.1002/9781119599586.ch13] [Reference Citation Analysis]
23 Agarwal HS, Latifi SQ. Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine. Pathogens 2021;10:727. [PMID: 34207609 DOI: 10.3390/pathogens10060727] [Reference Citation Analysis]
24 Weintraub L, Ahluwalia M, Dogra S, Uehlinger J, Skversky A, Vasovic L. Management of streptococcal pneumoniae-induced hemolytic uremic syndrome: a case report. Clin Nephrol Case Stud 2014;2:9-17. [PMID: 29043123 DOI: 10.5414/CNCS107887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122:10-23. [PMID: 12823341 DOI: 10.1046/j.1365-2141.2003.04468.x] [Cited by in Crossref: 430] [Cited by in F6Publishing: 344] [Article Influence: 22.6] [Reference Citation Analysis]
26 Huang YH, Lin TY, Wong KS, Huang YC, Chiu CH, Lai SH, Hsia SH. Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan. Eur J Pediatr 2006;165:332-5. [PMID: 16501993 DOI: 10.1007/s00431-005-0041-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
27 Jacquot C, Pary PP, Babu V, Belay E, Mo YD, Webb JL, Luban NLC, Delaney M. Erythrocyte T-antigen activation in children: Patient characteristics and the hemolytic risk of transfusion. Pediatr Blood Cancer 2021;68:e29082. [PMID: 33900685 DOI: 10.1002/pbc.29082] [Reference Citation Analysis]
28 Wang Q, Liu D, Bai Y. T-cryptantigen (TCA) activation in sever pneumonia complicated with multiple organ failure. Transfusion and Apheresis Science 2010;43:361-4. [DOI: 10.1016/j.transci.2010.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Chang CJ, Chiu NC, Huang FY, Tsung-Ning Huang D, Chang L, Huang CY, Kung YH, Chi H. Predictive value of Thomsen-Friedenreich antigen activation for Streptococcus pneumoniae infection and severity in pediatric lobar pneumonia. J Microbiol Immunol Infect 2019;52:571-7. [PMID: 28918242 DOI: 10.1016/j.jmii.2017.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
30 Moh-klaren J, Bodivit G, Jugie M, Chadebech P, Chevret L, Mokhtari M, Chamillard X, Gallon P, Tissières P, Bierling P, Djoudi R, Pirenne F, Burin-des-roziers N. Severe hemolysis after plasma transfusion in a neonate with necrotizing enterocolitis, Clostridium perfringens infection, and red blood cell T-polyagglutination: T-ANTIGEN ACTIVATION AND HEMOLYSIS IN NEC. Transfusion 2017;57:2571-7. [DOI: 10.1111/trf.14196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
31 Yudin J, Heddle NM. A 13-Question Approach to Resolving Serological Discrepancies in the Transfusion Medicine Laboratory. Lab Med 2014;45:193-206. [DOI: 10.1309/lmewvsnt2f3o5jdn] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
32 Cooling L. Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev 2015;28:801-70. [PMID: 26085552 DOI: 10.1128/CMR.00109-14] [Cited by in Crossref: 206] [Cited by in F6Publishing: 103] [Article Influence: 29.4] [Reference Citation Analysis]
33 New HV, Berryman J, Bolton-maggs PHB, Cantwell C, Chalmers EA, Davies T, Gottstein R, Kelleher A, Kumar S, Morley SL, Stanworth SJ; the British Committee for Standards in Haematology. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol 2016;175:784-828. [DOI: 10.1111/bjh.14233] [Cited by in Crossref: 122] [Cited by in F6Publishing: 95] [Article Influence: 20.3] [Reference Citation Analysis]
34 Bitzan M, Lapeyraque A. Postinfectious Hemolytic Uremic Syndrome. In: Geary DF, Schaefer F, editors. Pediatric Kidney Disease. Berlin: Springer Berlin Heidelberg; 2016. pp. 653-731. [DOI: 10.1007/978-3-662-52972-0_26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
35 Eder AF, Manno CS. Does red-cell T activation matter?: Annotation. British Journal of Haematology 2001;114:25-30. [DOI: 10.1046/j.1365-2141.2001.02886.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
36 Burin des Roziers N, Chadebech P, Bodivit G, Guinchard E, Bruneel A, Dupré T, Chevret L, Jugie M, Gallon P, Bierling P, Noizat-Pirenne F. Red blood cell Thomsen-Friedenreich antigen expression and galectin-3 plasma concentrations in Streptococcus pneumoniae-associated hemolytic uremic syndrome and hemolytic anemia.Transfusion. 2015;55:1563-1571. [PMID: 25556575 DOI: 10.1111/trf.12981] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
37 Loirat C, Saland J, Bitzan M. Management of hemolytic uremic syndrome. Presse Med. 2012;41:e115-e135. [PMID: 22284541 DOI: 10.1016/j.lpm.2011.11.013] [Cited by in Crossref: 69] [Cited by in F6Publishing: 45] [Article Influence: 6.9] [Reference Citation Analysis]
38 Yamada C, Davenport RD. A case of extravascular hemolysis with Tk-activation. Clin Case Rep 2014;2:137-42. [PMID: 25356271 DOI: 10.1002/ccr3.80] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Fàbregas Martori A, Moraga-Llop F, Nieto Rey J, Figueras Nadal C, Soler Palacín P, Roqueta Mas J. [Invasive pneumococcal disease and hemolytic uremic syndrome]. An Pediatr (Barc) 2008;68:269-72. [PMID: 18358139 DOI: 10.1157/13116708] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
40 Roseff SD. Cryptantigens: time to uncover the real significance of T-activation: EDITORIAL. Transfusion 2017;57:2553-7. [DOI: 10.1111/trf.14366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]